However, it is important to emphasize that although research in this field is promising, clinical applications may vary, and further studies and clinical trials are necessary to establish the safety and efficacy of HDAC inhibitors in specific cancer types [15,16,17,18,19,20]. This evidence concerns the gene HDAC9 and cancer.